365 / 1631
Consolidation radiotherapy in patients with advanced Hodgkin's
lymphoma: survival data from the UKLG LY09 randomized
controlled trial
• With a median follow-up of 6.9
years, outcome superior for
patients having RT
• 5-year PFS 86% vs 71%
• (HR = 0.43; P<.0001)
• Similar advantage was seen
for overall survival
• HR = 0.47 (95%CI = 0.29 to
0.77; p = 0.0014).
Johnson P et al J Clin Oncol. 2010 Jul 10;28(20):3352-9